The potential advantage of omapatrilat: Dual anti-fibrotic and anti-inflammatory effects in one single molecule

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)273-275
Number of pages3
JournalJournal of Hypertension
Volume23
Issue number2
DOIs
Publication statusPublished - Feb 2005

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine

Cite this

@article{09165e8ad5c045bc92c0bb041d7bf060,
title = "The potential advantage of omapatrilat: Dual anti-fibrotic and anti-inflammatory effects in one single molecule",
author = "Stefano Perlini",
year = "2005",
month = "2",
doi = "10.1097/00004872-200502000-00007",
language = "English",
volume = "23",
pages = "273--275",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The potential advantage of omapatrilat

T2 - Dual anti-fibrotic and anti-inflammatory effects in one single molecule

AU - Perlini, Stefano

PY - 2005/2

Y1 - 2005/2

UR - http://www.scopus.com/inward/record.url?scp=14044270788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14044270788&partnerID=8YFLogxK

U2 - 10.1097/00004872-200502000-00007

DO - 10.1097/00004872-200502000-00007

M3 - Article

C2 - 15662213

AN - SCOPUS:14044270788

VL - 23

SP - 273

EP - 275

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 2

ER -